Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Eli Lilly and Co. has begun selling its blockbuster weight-loss and diabetes drug Mounjaro in India, pipping rivals in a ...

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...

Eli Lilly and Company’s LLY shares dipped almost 5% on Monday after rival Novo Nordisk NVO announced disappointing data from ...

For example, one 3-mg tablet of Rybelsus formulation R1 is not equivalent to two 1.5-mg tablets of formulation R2. If you have questions about the differences between each Rybelsus formulation ...

With the emergence and approval of other new oral anticoagulants such as dabigatran and rivaroxaban, the role of and place in therapy for all of these new agents will have to be clearly delineated.

For those seeking the ultimate LTE tablet experience in 2025, this article highlights the top five options, each offering cutting-edge cellular connectivity and the latest technology. Designed ...

It’s important to note that these formulations cannot be used interchangeably. For example, two 1.5-mg tablets in formulation R2 are not equivalent to one 3-mg tablet in formulation R1.

India’s tablet market witnessed significant growth in 2024 with registering a 25 percent year-on-year (YoY) increase, a report said. The growth was primarily driven by a surge in 5G tablet shipments, ...

Patients assigned to rivaroxaban receive this drug + warfarin-placebo with sham INR values ... AVERROES (NCT00496769) is a double-blind, double-dummy, phase III trial comparing apixaban 5 mg twice ...